reference/24833609

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24833609

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	207
issn	1940-6215 1940-6207
issueIdentifier	3
pageRange	201-207
publicationName	Cancer prevention research (Philadelphia, Pa.)
startingPage	201
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6720797a24d919b46cd6ccb7319d730d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9569fc20b812324133e33485380f91d8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fe777c7c6550cff6062629dbb19aa827
bibliographicCitation	Zhang J, Iwanaga K, Choi KC, Wislez M, Raso MG, Wei W, Wistuba II, Kurie JM. Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cells. Cancer Prev Res (Phila). 2008 Aug;1(3):201–7. PMID: 19138957; PMCID: PMC3375599.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1628cab116ba08414ac8360d544203e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43f6715875e28de9b4303e959335dded http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_637a5b8ec7e5b5d8fa3d9e2a78dc94bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_863c48ea4cdf7e4665c83b9eedaa5806 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7518-7859 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e05dbae976d05e2b75abbd1ab90f47be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc383e2ffa465257cb1e360194af4533 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc9cf5a11c29c26583eafdeb6ae4f404 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db5ab8b84b44d90812c3df7b2c582901
date	2008-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC3375599 https://pubmed.ncbi.nlm.nih.gov/19138957 https://doi.org/10.1158/1940-6207.capr-08-0014
isPartOf	https://portal.issn.org/resource/ISSN/1940-6207 https://portal.issn.org/resource/ISSN/1940-6215 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34798
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties onEGFR-Mutant Cells
discusses	http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0593417 http://id.nlm.nih.gov/mesh/M0593434 http://id.nlm.nih.gov/mesh/M0007549
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D004815Q000235 http://id.nlm.nih.gov/mesh/D018773 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D008175Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004815Q000378 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D066260 http://id.nlm.nih.gov/mesh/D002470Q000235 http://id.nlm.nih.gov/mesh/D046888 http://id.nlm.nih.gov/mesh/D009154Q000502 http://id.nlm.nih.gov/mesh/D002289Q000378 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D002289Q000601 http://id.nlm.nih.gov/mesh/D008207 http://id.nlm.nih.gov/mesh/D008175Q000601 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4496a4721ecb4cdce12b2b73e7a635c4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2069

Total number of triples: 68.